ATE332964T1 - Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe - Google Patents

Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe

Info

Publication number
ATE332964T1
ATE332964T1 AT01964073T AT01964073T ATE332964T1 AT E332964 T1 ATE332964 T1 AT E332964T1 AT 01964073 T AT01964073 T AT 01964073T AT 01964073 T AT01964073 T AT 01964073T AT E332964 T1 ATE332964 T1 AT E332964T1
Authority
AT
Austria
Prior art keywords
construct
decellularized
tissue
objects
engineered
Prior art date
Application number
AT01964073T
Other languages
English (en)
Inventor
Shannon Mitchell
Jennifer Koh
Laura E Niklason
Vikas Prabhakar
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Application granted granted Critical
Publication of ATE332964T1 publication Critical patent/ATE332964T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Transplantation (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT01964073T 2000-08-16 2001-08-16 Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe ATE332964T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22569800P 2000-08-16 2000-08-16
US09/931,506 US6962814B2 (en) 2000-08-16 2001-08-16 Decellularized tissue engineered constructs and tissues

Publications (1)

Publication Number Publication Date
ATE332964T1 true ATE332964T1 (de) 2006-08-15

Family

ID=26919836

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01964073T ATE332964T1 (de) 2000-08-16 2001-08-16 Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe

Country Status (7)

Country Link
US (4) US6962814B2 (de)
EP (1) EP1315796B1 (de)
AT (1) ATE332964T1 (de)
AU (1) AU2001284968B2 (de)
CA (1) CA2419817C (de)
DE (1) DE60121450T2 (de)
WO (1) WO2002014480A2 (de)

Families Citing this family (210)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485723B1 (en) * 1995-02-10 2002-11-26 Purdue Research Foundation Enhanced submucosal tissue graft constructs
US8563232B2 (en) 2000-09-12 2013-10-22 Lifenet Health Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US20080077251A1 (en) * 1999-06-07 2008-03-27 Chen Silvia S Cleaning and devitalization of cartilage
US6793677B2 (en) * 1999-08-13 2004-09-21 Bret A. Ferree Method of providing cells and other biologic materials for transplantation
US6576265B1 (en) 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
US20040043006A1 (en) * 2002-08-27 2004-03-04 Badylak Stephen F. Tissue regenerative composition
AU2001284968B2 (en) * 2000-08-16 2006-12-21 Duke University Decellularized tissue engineered constructs and tissues
US6599526B2 (en) * 2000-08-18 2003-07-29 The University Of North Texas Health Science Center At Fort Worth Pericardial anti-adhesion patch
US20020146817A1 (en) * 2000-10-02 2002-10-10 Cannon Thomas F. Automated bioculture and bioculture experiments system
US20040151705A1 (en) * 2002-03-22 2004-08-05 Shuichi Mizuno Neo-cartilage constructs and a method for preparation thereof
GB2375771A (en) * 2001-05-24 2002-11-27 Univ Leeds Decellularisation of tissue implant material
US7297540B2 (en) * 2002-01-15 2007-11-20 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs
EP1482871A4 (de) * 2002-02-19 2006-09-13 Bioarttis Inc Künstliches gefässgerüst und künstliche organe daraus
US20030187515A1 (en) * 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
EP2103684A1 (de) 2002-05-02 2009-09-23 Purdue Research Foundation Gefäßneubildungserweiterte Transplantationskonstrukte
JP2005533535A (ja) * 2002-05-02 2005-11-10 パーデュー・リサーチ・ファウンデーション 血管新生が促進された移植片構成物
US20050202058A1 (en) * 2002-05-02 2005-09-15 Hiles Michael C. Cell-seeded extracellular matrix grafts
CN1684589A (zh) 2002-05-02 2005-10-19 普渡研究基金会 血管化增强的移植构造物
US20040072294A1 (en) * 2002-06-19 2004-04-15 Braunhut Susan J. Tissue reconstruction and regeneration
US11243494B2 (en) 2002-07-31 2022-02-08 Abs Global, Inc. Multiple laminar flow-based particle and cellular separation with laser steering
JP4092397B2 (ja) * 2002-09-10 2008-05-28 国立循環器病センター総長 超高静水圧印加による移植用生体組織の処理方法
WO2004030626A2 (en) * 2002-09-30 2004-04-15 Massachussetts Eye & Ear Infirmary In vitro culture of tissue structures
US20040151729A1 (en) * 2002-10-28 2004-08-05 George Michalopoulos Novel long-term three-dimensional culture system
US7627373B2 (en) 2002-11-30 2009-12-01 Cardiac Pacemakers, Inc. Method and apparatus for cell and electrical therapy of living tissue
US20040175366A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Scaffold for cell growth and differentiation
US20040176855A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Decellularized liver for repair of tissue and treatment of organ deficiency
WO2005007233A2 (en) * 2003-06-20 2005-01-27 Massachusetts Institute Of Technology Application of electrical stimulation for functional tissue engineering in vitro and in vivo
US20050025838A1 (en) 2003-06-25 2005-02-03 Badylak Stephen F. Conditioned compositions for tissue restoration
US7326571B2 (en) * 2003-07-17 2008-02-05 Boston Scientific Scimed, Inc. Decellularized bone marrow extracellular matrix
US20050013870A1 (en) * 2003-07-17 2005-01-20 Toby Freyman Decellularized extracellular matrix of conditioned body tissues and uses thereof
DE10333863A1 (de) * 2003-07-24 2005-02-17 Walles, Thorsten Dr. Med. Bioartifizielles, primär vaskularisiertes Testgewebe für pharmakologische Testverfahren, Verfahren zu dessen Herstellung und Testverfahren unter dessen Verwendung sowie Bioreaktor zur Durchführung der Verfahren
US7744869B2 (en) * 2003-08-20 2010-06-29 Ebi, Llc Methods of treatment using electromagnetic field stimulated mesenchymal stem cells
WO2005021730A2 (en) * 2003-09-02 2005-03-10 University Of North Carolina At Chapel Hill Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells
GB2423934B (en) * 2003-09-04 2007-11-28 Cook Biotech Inc Extracellular matrix composite materials, and manufacture and use thereof
US20050125049A1 (en) * 2003-10-21 2005-06-09 The Regents Of The University Of Michigan Tissue engineered vascular construct and method for producing same
US7840263B2 (en) 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
DK1734814T3 (en) * 2004-03-17 2015-04-07 Revivicor Inc Tissue DERIVED FROM ANIMALS IS MISSING ANY EXPRESSION OF FUNCTIONAL ALPHA-1,3 galactosyltransferase
US20050266390A1 (en) * 2004-06-01 2005-12-01 Yuichiro Ueda Processes for removing cells and cell debris from tissue and tissue constructs used in transplantation and tissue reconstruction
WO2005118014A2 (en) * 2004-06-01 2005-12-15 Medtronic, Inc. Decellurisation processes for making bioprotheses
US7764995B2 (en) 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US8060219B2 (en) 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
US8874204B2 (en) * 2004-12-20 2014-10-28 Cardiac Pacemakers, Inc. Implantable medical devices comprising isolated extracellular matrix
US20060172315A1 (en) * 2005-02-01 2006-08-03 Anderson Amy L Methods for staining cells for identification and sorting
EP1693025A1 (de) 2005-02-17 2006-08-23 Universität Zürich Verfahren zur Herstellung einer Prothese aus Gewebe
US8445278B2 (en) * 2005-03-01 2013-05-21 Medtronic, Inc. Process for producing decellularized biological tissues
WO2006095342A2 (en) * 2005-03-07 2006-09-14 Technion Research & Development Foundation Ltd. Natural tissue-derived decellularized matrix and methods of generating and using same
WO2006113382A2 (en) 2005-04-15 2006-10-26 Wake Forest University Health Sciences Bioreactor system and method of enhancing functionality of muscle cultured in vitro
DE102005023599A1 (de) * 2005-05-18 2006-11-23 Corlife Gbr (Vertretungsberechtigte Gesellschafter: Prof. Dr. Alex Haverich Bioartifizielles Herzgewebetransplantat und Verfahren zu seiner Herstellung
US7840272B2 (en) 2005-06-03 2010-11-23 Medrelief Inc. Methods for modulating osteochondral development using bioelectrical stimulation
AU2006265601A1 (en) * 2005-06-30 2007-01-11 Anthrogenesis Corporation Repair of tympanic membrane using placenta derived collagen biofabric
ATE552007T1 (de) * 2005-08-26 2012-04-15 Univ Minnesota Dezellularisierung und rezellularisierung von organen und geweben
US20100093066A1 (en) * 2005-08-26 2010-04-15 Regents Of The University Of Minnesota Decellularization and recellularization apparatuses and systems containing the same
CA2623106C (en) 2005-09-19 2013-12-24 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
EP1965812A4 (de) * 2005-11-08 2010-02-24 Georgia Tech Res Inst Azellularisiertes biologisches material aus embryonalen stammzellen
EP2031968B1 (de) 2006-04-21 2017-11-22 Wake Forest University Health Sciences Strukturell modifizierte azelluläre gewebe-engineering-gerüste und herstellungsverfahren
WO2008021391A1 (en) * 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
KR100816395B1 (ko) * 2006-09-21 2008-03-27 (주)필미아젠 세포 유래 세포외기질막의 제조방법
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
AU2007318210B2 (en) * 2006-10-06 2014-02-20 Celularity Inc. Native (telopeptide) placental collagen compositions
US8105380B2 (en) * 2006-10-23 2012-01-31 Stemedica Cell Technologies, Inc. Cellular scaffold
US8709081B2 (en) 2006-10-23 2014-04-29 Stemedica Cell Technologies, Inc. Cellular scaffold
JP5732197B2 (ja) * 2006-11-16 2015-06-10 ユニヴァーシティ・オヴ・リーズ 半月板インプランテーションのための組織の調製
US8764828B2 (en) * 2007-02-02 2014-07-01 The Regents Of The University Of Michigan System and method for forming bone, ligament, and bone-ligament constructs
WO2008109407A2 (en) 2007-03-02 2008-09-12 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Extracellular matrix-derived gels and related methods
PT2164993T (pt) 2007-05-29 2017-01-12 Reid Christopher B Métodos para produção e usos de populações de células multipotentes, populações de células pluripotentes, populações de célula diferenciadas e populações de células resistentes a vih
US9421304B2 (en) 2007-07-03 2016-08-23 Histogenics Corporation Method for improvement of differentiation of mesenchymal stem cells using a double-structured tissue implant
US8685107B2 (en) 2007-07-03 2014-04-01 Histogenics Corporation Double-structured tissue implant and a method for preparation and use thereof
US20090054984A1 (en) 2007-08-20 2009-02-26 Histogenics Corporation Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
US9125743B2 (en) * 2007-07-16 2015-09-08 Lifenet Health Devitalization and recellularization of cartilage
US9744043B2 (en) 2007-07-16 2017-08-29 Lifenet Health Crafting of cartilage
US8198245B2 (en) * 2007-07-27 2012-06-12 Humacyte, Inc. Compositions and methods for soft tissue augmentation
US9144627B2 (en) 2007-09-14 2015-09-29 Exogenesis Corporation Methods for improving the bioactivity characteristics of a surface and objects with surfaces improved thereby
US8377460B2 (en) * 2007-09-14 2013-02-19 Exogenesis Corporation Method for modifying the wettability and/or other biocompatibility characteristics of a surface of a biological material by the application of gas cluster ion beam technology and biological materials made thereby
US20100227523A1 (en) * 2007-09-14 2010-09-09 Exogenesis Corporation Methods for improving the bioactivity characteristics of a surface and objects with surfaces improved thereby
JP5107680B2 (ja) * 2007-11-16 2012-12-26 パナソニック株式会社 半導体装置
CN101274106B (zh) * 2008-03-24 2011-11-09 中山大学中山眼科中心 一种制备脱细胞基质的方法
US20130116799A1 (en) * 2008-03-27 2013-05-09 The Cleveland Clinic Foundation Reinforced tissue graft
US10702326B2 (en) 2011-07-15 2020-07-07 Virginia Tech Intellectual Properties, Inc. Device and method for electroporation based treatment of stenosis of a tubular body part
US10238447B2 (en) 2008-04-29 2019-03-26 Virginia Tech Intellectual Properties, Inc. System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
US8992517B2 (en) 2008-04-29 2015-03-31 Virginia Tech Intellectual Properties Inc. Irreversible electroporation to treat aberrant cell masses
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US10272178B2 (en) 2008-04-29 2019-04-30 Virginia Tech Intellectual Properties Inc. Methods for blood-brain barrier disruption using electrical energy
US10245098B2 (en) 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Acute blood-brain barrier disruption using electrical energy based therapy
US9198733B2 (en) 2008-04-29 2015-12-01 Virginia Tech Intellectual Properties, Inc. Treatment planning for electroporation-based therapies
US9283051B2 (en) 2008-04-29 2016-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating a treatment volume for administering electrical-energy based therapies
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
WO2009134876A1 (en) * 2008-04-29 2009-11-05 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation to create tissue scaffolds
US11272979B2 (en) 2008-04-29 2022-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US11254926B2 (en) 2008-04-29 2022-02-22 Virginia Tech Intellectual Properties, Inc. Devices and methods for high frequency electroporation
WO2009152174A1 (en) * 2008-06-09 2009-12-17 The Children's Mercy Hospital Tissue retaining system
DK2326336T3 (en) * 2008-07-30 2015-07-27 Mesynthes Ltd Tissue support structures from the extracellular matrix of a preform
RU2011122956A (ru) * 2008-12-31 2013-02-10 КейСиАй ЛАЙСЕНЗИНГ, ИНК. Система для обеспечения потока текучей среды к нервным тканям
KR101822662B1 (ko) * 2009-02-04 2018-01-26 예일 유니버시티 폐 조직 엔지니어링
WO2010099310A1 (en) 2009-02-26 2010-09-02 Wake Forest University Health Sciences Endothelial scaffolds
US8685634B2 (en) 2009-03-06 2014-04-01 University of Pittsburgh—of the Commonwealth System of Higher Education Neural scaffolds
US8173420B2 (en) 2009-03-11 2012-05-08 Tissue Growth Technologies Corporation Cell seeding module
WO2010105054A1 (en) * 2009-03-11 2010-09-16 Exogenesis Corporation Method for modifying the wettability and/or other biocompatibility characteristics of a surface of a biological material by the application of gas cluster ion beam technology and biological materials made thereby
WO2010105102A1 (en) * 2009-03-11 2010-09-16 Exogenesis Corporation Methods for improving the bioactivity characteristics of a surface and objects with surfaces improved thereby
WO2010111263A1 (en) 2009-03-23 2010-09-30 Wake Forest University Health Sciences Tissue engineering scaffolds and methods of use
US8632534B2 (en) 2009-04-03 2014-01-21 Angiodynamics, Inc. Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD)
WO2010118387A1 (en) 2009-04-09 2010-10-14 Virginia Tech Intellectual Properties, Inc. Integration of very short electric pulses for minimally to noninvasive electroporation
US11638603B2 (en) 2009-04-09 2023-05-02 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US11382681B2 (en) 2009-04-09 2022-07-12 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
US20100267143A1 (en) * 2009-04-16 2010-10-21 Snu R&Db Foundation Method for Surface Modification of Polymeric Scaffold for Stem Cell Transplantation Using Decellularized Extracellular Matrix
WO2010135527A2 (en) * 2009-05-20 2010-11-25 Humacyte, Inc. Elastin for soft tissue augmentation
US8903488B2 (en) 2009-05-28 2014-12-02 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
US8298586B2 (en) 2009-07-22 2012-10-30 Acell Inc Variable density tissue graft composition
US8652500B2 (en) 2009-07-22 2014-02-18 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
US8507263B2 (en) * 2009-08-07 2013-08-13 Maria Adelaide Asnaghi Rotating bioreactor
US10016460B2 (en) 2009-11-27 2018-07-10 Stephen Anthony Livesey Method of inducing cellular growth and materials for use therewith
CN106362211A (zh) * 2010-07-02 2017-02-01 北卡罗来纳-查佩尔山大学 生物基质支架
WO2012021814A2 (en) 2010-08-13 2012-02-16 Wake Forest University Health Sciences Methods for making a tissue engineered muscle repair (temr) construct in vitro for implantation in vivo
SG188369A1 (en) 2010-09-01 2013-04-30 Univ Minnesota Methods of recellularizing a tissue or organ for improved transplantability
US9700368B2 (en) 2010-10-13 2017-07-11 Angiodynamics, Inc. System and method for electrically ablating tissue of a patient
US10908066B2 (en) 2010-11-16 2021-02-02 1087 Systems, Inc. Use of vibrational spectroscopy for microfluidic liquid measurement
WO2012088149A2 (en) 2010-12-20 2012-06-28 Virginia Tech Intellectual Properties, Inc. High-frequency electroporation for cancer therapy
US20130013083A1 (en) * 2011-01-06 2013-01-10 Humacyte Tissue-Engineered Constructs
JP5878181B2 (ja) * 2011-01-06 2016-03-08 ヒューマサイト 組織工学構築物
US10207025B2 (en) 2011-04-28 2019-02-19 Lifecell Corporation Method for enzymatic treatment of tissue products
US9238793B2 (en) 2011-04-28 2016-01-19 Lifecell Corporation Method for enzymatic treatment of tissue products
CN103491986B (zh) * 2011-04-28 2016-03-09 生命细胞公司 组织产品的酶处理方法
CN102260731B (zh) * 2011-06-28 2015-03-25 合肥安旸生物医药有限公司 用于膀胱癌筛查的酶标液基细胞学染色试剂盒
WO2013009595A2 (en) * 2011-07-08 2013-01-17 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Injectable cns-derived ecm for tissue reconstruction
US9315798B2 (en) 2011-08-22 2016-04-19 Exogenesis Corporation Methods for improving the bioactivity characteristics of a surface and objects with surfaces improved thereby
US9114195B2 (en) 2011-08-22 2015-08-25 Exogenesis Corporation Method for modifying the wettability and other biocompatibility characteristics of a surface of a biological material by the application of beam technology and biological materials made thereby
US9078665B2 (en) 2011-09-28 2015-07-14 Angiodynamics, Inc. Multiple treatment zone ablation probe
WO2013052138A2 (en) * 2011-10-03 2013-04-11 Fabrico. Inc. System and method for electrophoretic decellularization
WO2013056049A2 (en) * 2011-10-14 2013-04-18 Humacyte, Inc. Tubular prostheses
US8986378B2 (en) 2011-11-02 2015-03-24 Mimedx Group, Inc. Implantable collagen devices and related methods and systems of making same
WO2013089808A1 (en) * 2011-12-14 2013-06-20 Edmund Burke Decellularized small particle tissue
US9606035B2 (en) 2011-12-21 2017-03-28 Ta Instruments-Waters Llc System for mechanical stimulation and characterization of biologic samples
WO2013114372A1 (en) 2012-02-01 2013-08-08 Nayacure Therapeutics Ltd. Method for inducing immune tolerance to organ transplants
US9414881B2 (en) 2012-02-08 2016-08-16 Angiodynamics, Inc. System and method for increasing a target zone for electrical ablation
US9877822B2 (en) 2012-04-24 2018-01-30 Biostage, Inc. Engineered tissue scaffolds and supports therefor
US20130344490A1 (en) * 2012-04-27 2013-12-26 Min Peter Kim Neoplastic cells grown on decellularized biomatrix
US9290738B2 (en) 2012-06-13 2016-03-22 Miromatrix Medical Inc. Methods of decellularizing bone
BR112014029505B1 (pt) * 2012-06-14 2021-11-16 Greiner Bio-One North America, Inc Método de fazer uma matriz extracelular (ecm) magnética e método de preparar tecido para implantação em um paciente
US20140023722A1 (en) * 2012-07-20 2014-01-23 Alan V. Boruch Neural Scaffold Biomaterial
HK1217663A1 (zh) 2013-01-09 2017-01-20 Harvard Apparatus Regenerative Technology, Inc. 合成支架
US9888956B2 (en) 2013-01-22 2018-02-13 Angiodynamics, Inc. Integrated pump and generator device and method of use
CN103041450B (zh) * 2013-01-25 2015-06-10 南通大学 用于修复周围神经损伤的细胞基质修饰的组织工程神经移植物及其制备方法
DK2968673T3 (da) * 2013-03-15 2021-07-12 Univ Florida Fremgangsmåde til decellularisering af vævstransplantater
KR102278652B1 (ko) 2013-03-15 2021-07-19 미로매트릭스 메디칼 인크. 섬 세포 재세포화를 위한 관류 탈세포화된 간의 용도
CN104278008B (zh) 2013-07-12 2020-08-21 北京宏冠再生医学科技有限公司 一种通过小分子化合物处理来制备多潜能干细胞的方法、试剂盒和用途
US8961904B2 (en) 2013-07-16 2015-02-24 Premium Genetics (Uk) Ltd. Microfluidic chip
US9878071B2 (en) 2013-10-16 2018-01-30 Purdue Research Foundation Collagen compositions and methods of use
US11796449B2 (en) 2013-10-30 2023-10-24 Abs Global, Inc. Microfluidic system and method with focused energy apparatus
ES2846758T3 (es) 2013-11-04 2021-07-29 Lifecell Corp Métodos para eliminar la alfa-galactosa
KR101636954B1 (ko) * 2013-11-04 2016-07-08 대한민국 재세포화된 바이오 스캐폴드 및 이의 제조방법
US9999707B2 (en) * 2014-03-04 2018-06-19 University of Pittsburgh—of the Commonwealth System of Higher Education Method for decellularization of tissue
CN106456837B (zh) 2014-03-21 2020-04-10 匹兹堡大学-联邦高等教育体系 最终消毒的来自细胞外基质的水凝胶的制备方法
CN112807074A (zh) 2014-05-12 2021-05-18 弗吉尼亚暨州立大学知识产权公司 电穿孔系统
US10293082B2 (en) * 2014-07-23 2019-05-21 Clemson University Research Foundation Decellularization method and system and decellularized tissue formed thereby
EP4548939A3 (de) 2014-08-27 2025-08-06 Purdue Research Foundation Abgabesysteme für therapeutikum auf kollagenbasis
US12114911B2 (en) 2014-08-28 2024-10-15 Angiodynamics, Inc. System and method for ablating a tissue site by electroporation with real-time pulse monitoring
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US10694972B2 (en) 2014-12-15 2020-06-30 Virginia Tech Intellectual Properties, Inc. Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
WO2016115489A1 (en) 2015-01-16 2016-07-21 Clemson University Research Foundation Tissues containing semiconductor nanomaterials and methods of preparing and using the same
SG11201706777QA (en) 2015-02-19 2017-09-28 Premium Genetics (Uk) Ltd Scanning infrared measurement system
CA2977462A1 (en) * 2015-02-27 2016-09-01 Adeka Corporation Decellularized tissue
CN104800890B (zh) * 2015-04-08 2017-05-17 中山大学 一种脱细胞颌下腺基质材料及其制备方法
US11919941B2 (en) 2015-04-21 2024-03-05 Purdue Research Foundation Cell-collagen-silica composites and methods of making and using the same
US20180228599A1 (en) * 2015-08-06 2018-08-16 The Johns Hopkins University Tissue-derived scaffolds for corneal reconstruction
US11028369B2 (en) 2015-08-13 2021-06-08 Beihao Stem Cell And Regenerative Medicine Research Institute Co., Ltd. Induced extended pluripotent stem cells, method of making and using
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
US20190282624A1 (en) 2015-11-30 2019-09-19 Beihao Stem Cell And Regenerative Medicine Research Institute Co., Ltd. Improved methods for reprograming non-pluripotent cells into pluripotent stem cells
US11458224B2 (en) * 2016-03-04 2022-10-04 University of Pittsburgh—of the Commonwealth System of Higher Education Ovarian-derived hydrogels for biomedical and biotechnology applications
CN115444935A (zh) 2016-06-15 2022-12-09 通用医疗公司 使用生物正交反应进行的生物材料的代谢标记和分子增强
EP3509651B1 (de) 2016-09-06 2022-12-28 Miromatrix Medical Inc. Verwendung von reseziertem leberserum zum engineering der ganzen leber
GB2555787A (en) 2016-11-07 2018-05-16 Landberg Goran Diagnostic methods
US10905492B2 (en) 2016-11-17 2021-02-02 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
CA3051245A1 (en) 2017-01-30 2018-08-02 Lifecell Corporation Tissue matrix materials and enzymatic adhesives
CN110290817B (zh) 2017-01-30 2020-07-03 生命细胞公司 转谷氨酰胺酶处理的产品
ES3040675T3 (en) 2017-01-31 2025-11-04 Geniphys Inc Methods and compositions for matrix preparation
AU2018226867B2 (en) 2017-03-02 2023-11-02 University Of Pittsburgh - Of The Commonwealth System Of Higher Education ECM hydrogel for treating esophageal inflammation
AU2018226871B2 (en) 2017-03-02 2023-08-10 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Extracellular matrix (ECM) hydrogel and soluble fraction thereof for the treatment of cancer
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
US11739291B2 (en) 2017-04-25 2023-08-29 Purdue Research Foundation 3-dimensional (3D) tissue-engineered muscle for tissue restoration
WO2018218480A1 (en) 2017-05-31 2018-12-06 Beihao Stem Cell And Regenerative Medicine Research Institute Co., Ltd. Methods for chemically induced lineage reprogramming
DK3678714T3 (da) 2017-09-04 2023-05-01 Univ Zuerich Vævsmanipuleret medicinsk indretning
US11607537B2 (en) 2017-12-05 2023-03-21 Virginia Tech Intellectual Properties, Inc. Method for treating neurological disorders, including tumors, with electroporation
US12390262B2 (en) 2018-03-13 2025-08-19 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
US11311329B2 (en) 2018-03-13 2022-04-26 Virginia Tech Intellectual Properties, Inc. Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
US11925405B2 (en) 2018-03-13 2024-03-12 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
WO2019226790A1 (en) 2018-05-23 2019-11-28 Abs Global, Inc. Systems and methods for particle focusing in microchannels
US12263275B2 (en) 2018-06-13 2025-04-01 Miromatrix Medical Inc. Fistula filler and deployment system
CN109453427A (zh) * 2018-11-30 2019-03-12 广州新诚生物科技有限公司 一种动物组织脱细胞化前的清洗方法
US20220071233A1 (en) * 2018-12-21 2022-03-10 Trustees Of Tufts College In vitro insect muscle as a nutrition source
EP3899489B1 (de) 2018-12-21 2025-04-09 ABS Global, Inc. System und verfahren zur identifizierung einer subpopulation
EP3955735B1 (de) 2019-04-18 2024-05-22 ABS Global, Inc. System und verfahren zur kontinuierlichen zugabe eines kryoprotektivums
US11950835B2 (en) 2019-06-28 2024-04-09 Virginia Tech Intellectual Properties, Inc. Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy
US12214189B2 (en) 2019-07-24 2025-02-04 Virginia Tech Intellectual Properties, Inc. Fourier analysis spectroscopy for monitoring tissue impedance changes and treatment outcome during electroporation-based-therapies
US11628439B2 (en) 2020-01-13 2023-04-18 Abs Global, Inc. Single-sheath microfluidic chip
CA3168904A1 (en) 2020-01-27 2021-08-05 Geniphys, Inc. Biologic filler for restoring and regenerating tissue
WO2021202564A1 (en) 2020-03-30 2021-10-07 King Abdullah University Of Science And Technology Compositions and methods for controlling cellular identity
US12497648B2 (en) 2020-10-21 2025-12-16 Abs Global, Inc. Methods and systems for processing genetic samples to determine identity or detect contamination
WO2022108840A1 (en) 2020-11-23 2022-05-27 Abs Global, Inc. Modular flow cytometry systems and methods of processing samples
US12485279B2 (en) 2020-11-25 2025-12-02 Virginia Tech Intellectual Properties, Inc. Methods for modulating temporal infrastructure of pulsed electric fields
GB2601793B (en) 2020-12-10 2025-07-23 The Francis Crick Institute Ltd Thymic constructs and uses thereof
US12383657B1 (en) 2021-06-09 2025-08-12 Reprise Biomedical, Inc. Biologic matrix for a wound site and related methods
US11998662B1 (en) 2021-06-09 2024-06-04 Reprise Biomedical, Inc. Biologic matrix for a wound site and related methods
US11376347B1 (en) * 2021-06-21 2022-07-05 The Florida International University Board Of Trustees Materials and methods for accelerating cardiovascular tissue regeneration
USD1118965S1 (en) 2021-11-12 2026-03-17 Abs Global, Inc. Flow cytometry device
GB202203756D0 (en) 2022-03-17 2022-05-04 Francis Crick Institute Ltd Thymic epithelial stem cells
EP4252790A1 (de) 2022-03-30 2023-10-04 Nordovo Biosciences As Verwendung von mikroträgern auf polymerbasis bei der produktion von gewebegerüsten mit komplexer geometrie
CN115227868B (zh) * 2022-07-20 2023-07-07 中南大学湘雅医院 骨缺损修复材料及镁预处理脱细胞组织工程骨支架
CN114949362B (zh) * 2022-07-29 2022-10-28 海迈医疗科技(苏州)有限公司 一种体内快速再细胞化组织工程血管及其制备方法
CN120204474B (zh) * 2025-05-27 2025-08-01 华中科技大学同济医学院附属协和医院 一种促内皮化的组织工程心脏瓣膜及其制备方法和应用

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US564756A (en) * 1896-07-28 Plant for heating greenhouses
US4559298A (en) 1982-11-23 1985-12-17 American National Red Cross Cryopreservation of biological materials in a non-frozen or vitreous state
US4801299A (en) * 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
US5266480A (en) 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
GB8618374D0 (en) 1986-07-28 1986-09-03 Hsc Res Dev Corp Biological vascular prostheses
CA1340581C (en) 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US4890457A (en) 1987-01-02 1990-01-02 Cryolife, Inc. Method for cryopreserving heart valves
US5145769A (en) 1987-08-21 1992-09-08 Cryolife Inc. Method for cryopreserving blood vessels
US5158867A (en) 1987-08-21 1992-10-27 Cryolife Inc. Method for cryopreserving blood vessels
USD323895S (en) 1989-04-13 1992-02-11 Lifecell Corporation Cryo slammer for cooling tissue samples
US5131850A (en) 1989-11-03 1992-07-21 Cryolife, Inc. Method for cryopreserving musculoskeletal tissues
AU650045B2 (en) 1990-09-12 1994-06-09 Lifecell Corporation Method and apparatus for cryopreparation dry stabilization and rehydration of biological suspensions
US5336616A (en) 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
US5192312A (en) 1991-03-05 1993-03-09 Colorado State University Research Foundation Treated tissue for implantation and methods of treatment and use
JP2842943B2 (ja) * 1991-03-08 1999-01-06 敬二 伊垣 脈管ステントとその保持構造体および脈管ステント挿着装置
US5723282A (en) 1991-07-08 1998-03-03 The American National Red Cross Method of preparing organs for vitrification
US5217860A (en) 1991-07-08 1993-06-08 The American National Red Cross Method for preserving organs for transplantation by vitrification
US5800537A (en) * 1992-08-07 1998-09-01 Tissue Engineering, Inc. Method and construct for producing graft tissue from an extracellular matrix
EP0871414B1 (de) * 1994-03-14 2004-04-28 Cryolife, Inc Herstellungsverfahren von gewebe zur implantation
US5916265A (en) 1994-03-30 1999-06-29 Hu; Jie Method of producing a biological extracellular matrix for use as a cell seeding scaffold and implant
US5595571A (en) 1994-04-18 1997-01-21 Hancock Jaffe Laboratories Biological material pre-fixation treatment
US5716394A (en) * 1994-04-29 1998-02-10 W. L. Gore & Associates, Inc. Blood contact surfaces using extracellular matrix synthesized in vitro
JPH09512184A (ja) * 1994-04-29 1997-12-09 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 内皮下細胞外基質上の内皮を利用する改善された血液接触表面
US5622867A (en) 1994-10-19 1997-04-22 Lifecell Corporation Prolonged preservation of blood platelets
ZA963151B (en) * 1995-04-19 1997-04-24 St Jude Medical Matrix substrate for a viable body tissue-derived prosthesis and method for making the same
US5830708A (en) * 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
CA2230263A1 (en) 1995-08-25 1997-03-06 Lifecell Corporation Reconstituted skin
AU3229697A (en) * 1996-06-03 1998-01-05 Gore Enterprise Holdings, Inc. Improved blood contact surfaces using extracellular matrix synthesized (in vitro) having bioactive species immobilized thereto
WO1998019529A1 (en) 1996-11-07 1998-05-14 21St Century Medicine, Inc. A method for rapid cooling and warming of biological materials
US5899937A (en) 1997-03-05 1999-05-04 Cryolife, Inc. Pulsatile flow system for developing heart valves
ATE279163T1 (de) * 1997-04-11 2004-10-15 Cryolife Inc Gewebedezellularization
US6179872B1 (en) * 1998-03-17 2001-01-30 Tissue Engineering Biopolymer matt for use in tissue repair and reconstruction
US6743574B1 (en) * 2000-09-12 2004-06-01 Lifenet Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US6734018B2 (en) * 1999-06-07 2004-05-11 Lifenet Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced
PT1210428E (pt) 1999-08-23 2015-07-21 Genetics Inst Llc Pd-1, um recetor para b7-4 e suas utilizações
US6503273B1 (en) * 1999-11-22 2003-01-07 Cyograft Tissue Engineering, Inc. Tissue engineered blood vessels and methods and apparatus for their manufacture
US6432712B1 (en) * 1999-11-22 2002-08-13 Bioscience Consultants, Llc Transplantable recellularized and reendothelialized vascular tissue graft
US6376244B1 (en) 1999-12-29 2002-04-23 Children's Medical Center Corporation Methods and compositions for organ decellularization
US6866686B2 (en) * 2000-01-28 2005-03-15 Cryolife, Inc. Tissue graft
US6652583B2 (en) * 2000-04-07 2003-11-25 Rhode Island Hospital Cardiac valve replacement
US6689161B2 (en) * 2000-04-28 2004-02-10 Baylor College Of Medicine Decellularized vascular prostheses resistant to thrombus occlusion and immunologic rejection
AU2001284968B2 (en) * 2000-08-16 2006-12-21 Duke University Decellularized tissue engineered constructs and tissues
WO2002064022A2 (en) * 2001-02-14 2002-08-22 Duke University Therapy for cerebral vasospasm
AU2002364558A1 (en) * 2001-12-11 2003-06-23 Cytograft Tissue Engineering, Inc. Tissue engineered cellular sheets, methods of making and use thereof
ES2353665T3 (es) 2002-03-15 2011-03-03 Duke University Ingeniería tisular.
JP5232636B2 (ja) * 2005-03-11 2013-07-10 ウエイク・フオレスト・ユニバーシテイ・ヘルス・サイエンシズ 組織の工作された血管
US7658706B2 (en) * 2005-12-05 2010-02-09 Rti Biologics, Inc. Vascular graft sterilization and decellularization
GB0606231D0 (en) * 2006-03-29 2006-05-10 Univ Leeds Improvements relating to decellurisation of tissue matrices for bladder implantation

Also Published As

Publication number Publication date
US6962814B2 (en) 2005-11-08
WO2002014480A9 (en) 2003-03-27
WO2002014480A3 (en) 2002-08-01
US20060073590A1 (en) 2006-04-06
AU2001284968B2 (en) 2006-12-21
CA2419817C (en) 2014-11-18
EP1315796A2 (de) 2003-06-04
US20080248080A1 (en) 2008-10-09
DE60121450T2 (de) 2007-02-15
US20120135049A1 (en) 2012-05-31
WO2002014480A2 (en) 2002-02-21
US20020115208A1 (en) 2002-08-22
EP1315796B1 (de) 2006-07-12
CA2419817A1 (en) 2002-02-21
DE60121450D1 (de) 2006-08-24

Similar Documents

Publication Publication Date Title
DE60121450D1 (de) Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe
WO2002076285A3 (en) Composition and methods fro the production of biological tissues and tissue constructs
ATE526047T1 (de) Verbesserung der funktion von organen
DK1201749T3 (da) Fremgangsmåde til fremstilling af humane bruskimplantater ved hjælp af in vitro dyrkede chondrocytter
IL144446A0 (en) Plasma protein matrices and methods for their preparation
WO2002067867A3 (en) Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair
WO2007124127A3 (en) Structurally modified acellular tissue engineering scaffolds and methods of production
WO2003082201A3 (en) Collagen biofabric and methods of preparation and use therefor
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
WO2005007233A3 (en) Application of electrical stimulation for functional tissue engineering in vitro and in vivo
DK1311658T3 (da) Fremgangsmåde til fremstilling af brugsfærdige, eventuelt antigenholdige cryokonserverede modne dendritiske celler
AR054659A1 (es) Injerto de foliculos pilosos biomimeticos con tejido manipulado
MX2012004881A (es) Metodos para reprogramar células y sus usos.
DK0871414T3 (da) Fremgangsmåder til fremstilling af væv til implantering
ATE402002T1 (de) Elektroverarbeitetes kollagen
ES2530872T3 (es) Organos y células modificados para xenotrasplante
EP2172231A4 (de) Durch tissue-engineering hergestellte sehne und in vitro konstruktionsverfahren dafür
WO2005046445A3 (en) Artificial tissue systems and uses thereof
JP2002525043A5 (de)
EP1471788A4 (de) Verfahren zur induzierung der differenzierung in stammzellen, verfahren zur erzeugung von gewebe mit von mikroorganen und stammzellen abgeleiteten gerüstmatrizes, verfahren zur herstellung adulter stammzellen und verfahren zur kontinuierlichen erzeugung von stammzellen mittels implantation von mikroorganen als quellen für stammzellen
ATE263588T1 (de) Verfahren zur herstellung eines bioartifiziellen transplantates
ATE553186T1 (de) Bandscheibenreparatur und verfahren dafür
GB2456270A (en) Skin substitutes, preparation methods and uses thereof
DE502005006003D1 (de) Verfahren zur herstellung einer epithelzellen enthaltenden zellzusammensetzung
BR112022003045A2 (pt) Métodos para determinar a adequação de tecido de timo cultivado para o implante em humanos e métodos de uso associados

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties